Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Charmacy Pharmaceutical Co., Ltd. Class H ( (HK:2289) ) has shared an update.
Charmacy Pharmaceutical Co., Ltd. reported its annual financial results for the year ending December 31, 2024, showing a slight increase in operating revenue to RMB4,435.46 million, up 0.72% from the previous year. The company’s net profit also rose by 3.78% to RMB53.28 million. The board has recommended a final dividend of RMB0.45 per share. These results indicate a stable financial performance, reflecting the company’s steady position in the pharmaceutical market.
More about Charmacy Pharmaceutical Co., Ltd. Class H
Charmacy Pharmaceutical Co., Ltd. is a joint stock limited liability company incorporated in the People’s Republic of China, operating within the pharmaceutical industry. The company is primarily focused on the distribution and sale of pharmaceutical products.
YTD Price Performance: -20.61%
Average Trading Volume: 4,888
Technical Sentiment Signal: Buy
Current Market Cap: HK$840.2M
For a thorough assessment of 2289 stock, go to TipRanks’ Stock Analysis page.